Conmed (NYSE: CNMD) reported Q3 EPS of $0.77, $0.02 better than the analyst estimate of $0.75. Revenue for the quarter came in at $275.09 million versus the consensus estimate of $280.89 million.

For earnings history and earnings-related data on Conmed (CNMD) click here.